Tower Research Capital »

Brainstorm Cell Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $7.8k 39k 0.20
2023-06-30 $14k 6.9k 2.06
2023-03-31 $29k 8.9k 3.27
2022-12-31 $2.0k 1.1k 1.89
2022-06-30 $15k 5.5k 2.71
2021-12-31 $14k 3.4k 4.07
2021-03-31 $45k 12k 3.81
2020-12-31 $20k 4.3k 4.61
2020-09-30 $400k 24k 16.93
2020-06-30 $15k 1.3k 11.36
2020-03-31 $54k 12k 4.62
2019-12-31 $48k 11k 4.30
2019-09-30 $2.0k 641 3.12
2018-09-30 $3.0k 688 4.36
2018-06-30 $5.0k 1.4k 3.60
2018-03-31 $4.0k 1.2k 3.29
2017-12-31 $6.0k 1.5k 3.99
2017-09-30 $7.0k 1.8k 3.91
2016-09-30 $0 3 0.00
2016-03-31 $3.0k 999 3.00
2015-12-31 $1.0k 246 4.07
2015-09-30 $3.0k 1.2k 2.47
2015-06-30 $2.0k 474 4.22
2015-03-31 $999 127 7.87
2014-12-31 $0 0 0.00